V
Vinita Sharma
Researcher at Central University of Rajasthan
Publications - 6
Citations - 21
Vinita Sharma is an academic researcher from Central University of Rajasthan. The author has contributed to research in topics: Biology & Chemistry. The author has an hindex of 1, co-authored 3 publications receiving 2 citations.
Papers
More filters
Journal ArticleDOI
Immunoinformatics Approach to Design Multi-Epitope- Subunit Vaccine against Bovine Ephemeral Fever Disease
TL;DR: In this paper, a highly efficacious multi-epitope vaccine candidate was designed against the geographically distributed bovine ephemeral fever virus (BEFV) population.
Book ChapterDOI
Immunoinformatics and reverse vaccinology methods to design peptide-based vaccines
TL;DR: Reverse vaccinology (RV) as mentioned in this paper is an approach where the process starts from the roots of the organism, which are genomic and proteomic datasets of a pathogen, and involves the screening of all possible peptides to construct an efficient vaccine.
Journal ArticleDOI
Anti-IL-10 Antibody Humanization by SDR Grafting with Enhanced Affinity to Neutralize the Adverse Response of Interleukin-10
TL;DR:
Journal ArticleDOI
Immunoglobulin interface redesigning to enhance lebrikizumab mediated immunomodulation of IL-13 hyper-response.
Vinita Sharma,Priya Chouhan,Rajan Kumar Pandey,Rupal Ojha,Veeranarayanan Surya Aathmanathan,Muthukalingan Krishnan,Vijay Kumar Prajapati +6 more
TL;DR: This work has attempted to modulate the lebrikizumab mAb to enhance its binding affinity towards IL-13, and these redesigned mAb could be used for potential treatment against IL- 13 associated diseased conditions.
Journal ArticleDOI
Identification of multi-targeting natural antiviral peptides to impede SARS-CoV-2 infection
Satyendra Singh,P. Chauhan,Vinita Sharma,Abhishek Rao,Bajarang V. Kumbhar,Vijay Kumar Prajapati +5 more
TL;DR: In this paper , the authors applied structure-based virtual screening to identify potential peptides targeting the critical proteins of SARS-CoV-2, which can be used as a broad-spectrum drug and potentially develop as a therapeutic to combat the current pandemic.